Examkin

Question

Difficulty: HardImmunizations and Vaccine-Preventable Diseases

A 4-year-old girl is brought to the pediatrician in late September for a routine well-child visit. She has no significant past medical history and takes no medications. Her immunizations were up to date until age 2. Today, she is due for her preschool booster vaccines, which include DTaP, IPV, MMR, and varicella. Her parents also request that she receive her annual influenza vaccination. The patient lives at home with her parents and a 7-year-old brother who underwent an allogeneic hematopoietic stem cell transplant 6 weeks ago for acute myeloid leukemia; he currently requires a strictly protected environment in reverse isolation. Physical examination of the patient is unremarkable. What is the most appropriate action regarding this patient's immunizations today?

  1. Administer DTaP, IPV, MMR, varicella, and inactivated influenza vaccinesAnswer
  2. B
    Administer DTaP, IPV, MMR, varicella, and live-attenuated influenza vaccines
  3. C
    Administer DTaP, IPV, and inactivated influenza vaccines; defer MMR and varicella vaccines
  4. D
    Administer DTaP, IPV, and inactivated influenza vaccines; administer prophylactic immune globulin for measles and varicella
  5. E
    Defer all vaccinations until the brother is at least 6 months post-transplant

Answer

The most appropriate action is to administer the DTaP, IPV, MMR, varicella, and inactivated influenza vaccines.
The correct approach is to administer DTaP, IPV, MMR, varicella, and the inactivated influenza vaccine. It is crucial to maximize herd immunity (cocooning) around severely immunocompromised patients, such as this patient's brother who recently underwent a hematopoietic stem cell transplant. Routine inactivated vaccines (DTaP, IPV, inactivated influenza) carry absolutely no risk of transmission and are completely safe. Among live vaccines, the MMR and varicella vaccines are strongly recommended for household contacts. The measles, mumps, and rubella vaccine viruses do not shed. The varicella vaccine virus rarely sheds; if the vaccinated child develops a vesicular rash, they should be isolated from the immunocompromised sibling until the rash resolves, but the vaccine is not withheld. Conversely, the live-attenuated influenza vaccine (LAIV) contains cold-adapted viruses that can shed and be transmitted to severely immunosuppressed contacts. Therefore, the CDC specifically contraindicates LAIV for close contacts of individuals who require a strictly protected environment (e.g., within 2 months of a stem cell transplant). The inactivated influenza vaccine must be used instead.

Step-by-Step Solution

1
Identify the patient's vaccination needs based on age and season.
The 4-year-old patient requires routine boosters (DTaP, IPV, MMR, varicella) and an annual influenza vaccine.
This aligns with the standard CDC childhood immunization schedule for preschool-aged children.
2
Evaluate the household environment for contraindications.
The patient lives with a sibling who is 6 weeks post-hematopoietic stem cell transplant and requires a protected environment.
Live vaccines administered to healthy household contacts can sometimes shed and pose a transmission risk to severely immunocompromised individuals.
3
Determine which live vaccines are safe and which are contraindicated for this specific patient.
MMR and varicella are safe and highly recommended. Live-attenuated influenza vaccine (LAIV) is contraindicated.
MMR does not shed. Varicella vaccine virus transmission is extremely rare and only a risk if a rash develops. However, LAIV contains cold-adapted viruses that can shed and transmit, making it specifically contraindicated in close contacts of persons requiring a protected environment.

Key Concept

Healthy close contacts of severely immunocompromised individuals (e.g., recent stem cell transplant recipients in a protected environment) should receive all routine immunizations, including the live MMR and varicella vaccines, to provide 'cocooning' herd immunity. However, the live-attenuated influenza vaccine (LAIV) is specifically contraindicated due to the risk of shedding; the inactivated influenza vaccine (IIV) must be used instead.

Alternative Method

When evaluating pediatric immunizations, systematically categorize vaccines into 'inactivated' (always safe for contacts) and 'live' (requires contact screening). For live vaccines, memorize the single major exception: LAIV is contraindicated in contacts of those in a protected environment.
Estimated Time:1m 30s
Rate this question

Topics

Immunizations and Vaccine-Preventable Diseases

More questions from this topic